Paul Schimmel, Director at aTYR PHARMA INC (LIFE), bought 99,838 shares at $4.14 ($419K) on 2016-04-14, disclosed to the SEC on 2016-04-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.14 | 32,600 | $135K | 32.2% |
| 2 | $4.22 | 33,619 | $142K | 33.9% |
| 3 | $4.22 | 33,619 | $142K | 33.9% |
| Total | $4.19 avg | 99,838 | $419K | 100% |
| Filing → |
| ATYR | BUY | 2024-07-24 | $256K | — | Filing → |
| LIFE | BUY | 2023-05-11 | $450K | — | Filing → |
| LIFE | BUY | 2021-09-22 | $2.0M | — | Filing → |